923
Views
21
CrossRef citations to date
0
Altmetric
Research Paper

miR-20b-5p functions as tumor suppressor microRNA by targeting cyclinD1 in colon cancer

, , , , ORCID Icon &
Pages 2939-2954 | Received 15 May 2020, Accepted 16 Sep 2020, Published online: 12 Oct 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Yang Nan, Liyun Guo, Yingwei Zhen, Le Wang, Bingcheng Ren, Xingjie Chen, Yalin Lu, Kai Yu, Yue Zhong & Qiang Huang. (2021) miRNA-451 regulates the NF-κB signaling pathway by targeting IKKβ to inhibit glioma cell growth. Cell Cycle 20:19, pages 1967-1977.
Read now

Articles from other publishers (19)

Ruei-Ci Lin, Yu-Ying Chao, Mei-Tsz Su, Hui-Ling Tsai, Pei-Yin Tsai & Chia-Yih Wang. (2024) Upregulation of miR-20b-5p inhibits trophoblast invasion by blocking autophagy in recurrent miscarriage. Cellular Signalling 113, pages 110934.
Crossref
Elena Rahimi, Farzaneh Asefi, Ahmadreza Afzalinia, Somayeh Khezri, Hadi Zare-Zardini, Adel Ghorani-Azam, Ali Es-haghi & Mohammad Ehsan Taghavizadeh Yazdi. (2023) Chitosan coated copper/silver oxide nanoparticles as carriers of breast anticancer drug: Cyclin D1/P53 expressions and cytotoxicity studies. Inorganic Chemistry Communications 158, pages 111581.
Crossref
Sneha Krishnamoorthy, Bharathi Muruganantham, Jae- Ran Yu, Woo- Yoon Park & Sridhar Muthusami. (2023) Exploring the utility of FTS as a bonafide binding partner for EGFR: A potential drug target for cervical cancer. Computers in Biology and Medicine 167, pages 107592.
Crossref
Zengpeng Chi, Qimin Wang, Lei Tong, Jing Qiu, Fang Yang, Qingyuan Guo, Wenjian Li, Jiawei Zheng & Zhenggang Chen. (2023) Silencing geranylgeranyltransferase I inhibits the migration and invasion of salivary adenoid cystic carcinoma through RhoA/ROCK1/MLC signaling and suppresses proliferation through cell cycle regulation. Cell Biology International.
Crossref
Bei Xie, Lei Zhao, Zhewen Zhang, Cunmin Zhou, Ye Tian, Yingying Kang, Jing Chen, Hulai Wei & Linjing Li. (2023) CADM1 impairs the effect of miR-1246 on promoting cell cycle progression in chemo-resistant leukemia cells. BMC Cancer 23:1.
Crossref
Ondrej Pös, Jakub Styk, Gergely Buglyó, Michal Zeman, Lydia Lukyova, Kamila Bernatova, Evelina Hrckova Turnova, Tomas Rendek, Ádám Csók, Vanda Repiska, Bálint Nagy & Tomas Szemes. (2023) Cross-Kingdom Interaction of miRNAs and Gut Microbiota with Non-Invasive Diagnostic and Therapeutic Implications in Colorectal Cancer. International Journal of Molecular Sciences 24:13, pages 10520.
Crossref
Jan Roška, João Lobo, Danica Ivovič, Lenka Wachsmannová, Thomas Mueller, Rui Henrique, Carmen Jerónimo, Miroslav Chovanec & Dana Jurkovičová. (2023) Integrated Microarray-Based Data Analysis of miRNA Expression Profiles: Identification of Novel Biomarkers of Cisplatin-Resistance in Testicular Germ Cell Tumours. International Journal of Molecular Sciences 24:3, pages 2495.
Crossref
Yan Gao, Jing Geng, Zhuosong Xie, Ziying Zhou, Hexian Yang, Hong Yi, Xiaoyang Han, Situ Xue & Zhuorong Li. (2022) Synthesis and antineoplastic activity of ethylene glycol phenyl aminoethyl ether derivatives as FOXM1 inhibitors. European Journal of Medicinal Chemistry 244, pages 114877.
Crossref
Qi Guo, Lijia Zhang, Lei Zhao, Xueying Pang, Peng Wang, Heng Sun & Songjiang Liu. (2022) MEF2C-AS1 regulates its nearby gene MEF2C to mediate cervical cancer cell malignant phenotypes in vitro. Biochemical and Biophysical Research Communications 632, pages 48-54.
Crossref
Hao Zuo, Shiqi Liu, Xiangwei Li & Guowei Hou. (2022) miR-23a-3p promotes the development of colon cancer by inhibiting the expression of NDRG4. Clinical and Translational Oncology 25:4, pages 933-940.
Crossref
Soudeh Ghafouri-Fard, Tayyebeh Khoshbakht, Bashdar Mahmud Hussen, Peixin Dong, Nikolaus Gassler, Mohammad Taheri, Aria Baniahmad & Nader Akbari Dilmaghani. (2022) A review on the role of cyclin dependent kinases in cancers. Cancer Cell International 22:1.
Crossref
Tian-Yuan Zhai, Meng Dou, Yu-Bo Ma, Hong Wang, Fang Liu, Lian-Dong Zhang, Tie Chong, Zi-Ming Wang & Li Xue. (2022) miR-20b-5p is a novel biomarker for detecting prostate cancer. Oncology Letters 24:6.
Crossref
Bin Zhao, Yuncui Wang, Xingwang Zhao, Jian Ni, Xiaowen Zhu, Yan Fu & Fan Yang. (2022) SIRT1 enhances oxaliplatin resistance in colorectal cancer through microRNA‐20b‐3p/DEPDC1 axis. Cell Biology International.
Crossref
Yanzi Qin, Wenjun Zhao, Zhaogeng Cai, Qi Wang, Jin Gao, Hongfei Ci, Zhenzhong Feng & Li Ma. (2022) The Biomarker Like the Correlation between Vasculogenic Mimicry, Vascular Endothelial Cadherin, Sex-DeterminingRegion on Y-Box Transcription Factor 17, and Cyclin D1 in Oesophageal Squamous Cell Carcinoma. Journal of Oncology 2022, pages 1-17.
Crossref
Peng Zhang, Honglin Chen, Qi Shang, Guifeng Chen, Jiahui He, Gengyang Shen, Xiang Yu, Zhida Zhang, Wenhua Zhao, Guangye Zhu, Jinglin Huang, De Liang, Jingjing Tang, Jianchao Cui, Zhixiang Liu, Xiaobing Jiang & Hui Ren. (2022) Zuogui Pill Ameliorates Glucocorticoid-Induced Osteoporosis through ZNF702P-Based ceRNA Network: Bioinformatics Analysis and Experimental Validation. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-15.
Crossref
Sujin Choi, Soonchul Lee, Young-Hoon Han, Junwon Choi, Isaac Kim, Jusung Lee & Hyun-Ju An. (2022) miR-31-3p functions as a tumor suppressor by directly targeting GABBR2 in prostate cancer. Frontiers in Oncology 12.
Crossref
Ke Fu, Ke Zhang & Xiaoyu Zhang. (2022) LncRNA HOTAIR facilitates proliferation and represses apoptosis of retinoblastoma cells through the miR-20b-5p/RRM2/PI3K/AKT axis. Orphanet Journal of Rare Diseases 17:1.
Crossref
Yaqin Xu, Yingying Dong, Yunhua Deng, Qianrong Qi, Mi Wu, Hongmei Liang, Qiuyun She & Qing Guo. (2021) Identifying an lncRNA-Related ceRNA Network to Reveal Novel Targets for a Cutaneous Squamous Cell Carcinoma. Biology 10:5, pages 432.
Crossref
Zhiheng Cheng, Yifeng Dai, Wenhui Huang, Qingfu Zhong, Pei Zhu, Wenjuan Zhang, Zhihua Wu, Qing Lin, Huoyan Zhu, Longzhen Cui, Tingting Qian, Cong Deng, Lin Fu, Yan Liu & Tiansheng Zeng. (2021) Prognostic Value of MicroRNA-20b in Acute Myeloid Leukemia. Frontiers in Oncology 10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.